Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral microencapsulated ragweed pollen extract for seasonal allergic rhinitis
2006-005713-35Phase 3Completed
- Sponsor
- Curalogic
- Start
- Nov 2006
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Ragweed pollen extract in allergic rhinitis (AR) (2 arms), sponsored by Curalogic. Primary endpoint: Average total symptom score during peak ragweed pollen weeks. Started Nov 2006; status: completed.
02
Drugs
Ragweed pollen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2006-005713-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005713-35.